Mental Health DailyResearch. Evidence. Perspective.Published research on strattera.
A 2026 double-blind randomized controlled trial by Kappes et al. in Psychopharmacology found something the smart-drug users likely wouldn’t have predicted: a single 30 mg dose of methylpheni…
Read articleReports suggest that nearly 20% of all people in the United States are taking a psychiatric drug. This means that 1 out of every 5 people you see is on some sort of mind-altering medication.…
Read articleAn overwhelming majority of medications used to treat ADHD (attention-deficit/hyperactivity disorder) are classified as psychostimulants. Although psychostimulant drugs tend to have an immed…
Read articleStrattera (Atomoxetine) is a relatively well-known NRI (norepinephrine reuptake inhibitor) that is commonly used for the treatment of ADHD. Its mechanism of action involves inhibiting the re…
Read articleStrattera is an NRI or “norepinephrine reuptake inhibitor” meaning it prevents the reuptake of the neurotransmitter norepinephrine. This drug has been found clinically effective for treating…
Read articleStrattera (Atomoxetine) is a unique drug that was created to treat ADHD (attention-deficit hyperactivity disorder). Unlike common stimulants, it works by inhibiting the reuptake of the neuro…
Read article